1p36
Showing 1 - 25 of >10,000
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Hemodynamic Instability, Pain Trial in Stockholm (Chattanooga Physio, DJO, neuromuscular electrical stimulation)
Completed
- Hemodynamic Instability
- Pain
- Chattanooga Physio, DJO, neuromuscular electrical stimulation
-
Stockholm, SwedenKarolinska university Hospital
Oct 9, 2023
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)
Completed
- Plaque Psoriasis
- Roflumilast Cream 0.3%
- +2 more
-
Beverly Hills, California
- +29 more
Aug 31, 2022
Ceramic-on-Ceramic 36mm Acetabular Bearing Insert Post Approval
Active, not recruiting
- Non-inflammatory Degenerative Joint Disease
- +3 more
- COC 36mm
-
Sacramento, California
- +12 more
Jan 23, 2023
Postural Balance, Gait, Non-nutritive Sucking Trial in Roma (Pacifier)
Recruiting
- Postural Balance
- +5 more
- Pacifier
-
Roma, ItalyBambino Gesù Children's Hospital and Research Institute
Mar 11, 2022
CS1P1 PET Studies of Neuroinflammation in Parkinson Disease
Not yet recruiting
- Parkinson Disease
-
Saint Louis, MissouriWashington University School of Medicine
Oct 10, 2023
Inflammation in Alzheimer's Disease and Related Dementias Using
Recruiting
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Nov 9, 2023
Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide (Bempegaldesleukin, Pembrolizumab)
Terminated
- Metastatic Head and Neck Cancer
- Recurrent Head and Neck Cancer
-
Omaha, Nebraska
- +3 more
Dec 16, 2022
Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)
Active, not recruiting
- Atopic Dermatitis Eczema
- ARQ-151 Active
- ARQ-151 Vehicle
-
Montgomery, Alabama
- +48 more
Aug 10, 2022
Developmental Endothelial Locus-1, Platelet Count, and Soluble
Not yet recruiting
- Overweight and Obesity
- Platelet count
- +2 more
-
Aswan, EgyptAswan University Hospital
May 17, 2023
Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)
Recruiting
- Atopic Dermatitis Eczema
- ARQ-151 Active
- ARQ-151 Vehicle
-
Birmingham, Alabama
- +75 more
Jan 26, 2023
Scalp Psoriasis Trial in Canada, United States (ARQ-154 Foam 0.3%, ARQ-154 Vehicle)
Completed
- Scalp Psoriasis
- ARQ-154 Foam 0.3%
- ARQ-154 Vehicle
-
Scottsdale, Arizona
- +48 more
Aug 4, 2022
22q11 Deletion Syndrome, DiGeorge Syndrome, Trisomy 21 Trial in Worldwide
Completed
- 22q11 Deletion Syndrome
- +10 more
-
San Francisco, California
- +20 more
Jan 27, 2021
Quality of Life 1y and 2 y After VV-ECMO for COVID-19
Recruiting
- COVID-19 Acute Respiratory Distress Syndrome
- +3 more
- VV-ECMO
-
Ghent, BelgiumGhent university hospital
Mar 21, 2023
Adverse Childhood Experiences Trial in Austin (Moderate Intensity Exercise (one day), Placebo - Light Intensity Exercise (one
Not yet recruiting
- Adverse Childhood Experiences
- Moderate Intensity Exercise (one day)
- +7 more
-
Austin, TexasUniversity of Texas at Austin
Aug 7, 2023
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +5 more
- P-CD19CD20-ALLO1
- Rimiducid
-
La Jolla, California
- +7 more
Aug 25, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.1 GBq (30 mCi) of 177Lu-P17-087, 1.1 GBq (30 mCi) of
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- 1.1 GBq (30 mCi) of 177Lu-P17-087
- 1.1 GBq (30 mCi) of 177Lu-P17-088
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 30, 2022
Temperature; Extreme, Exposure Trial in Brussels (G210 incubator)
Recruiting
- Temperature; Extreme, Exposure
- G210 incubator
-
Brussels, BelgiumUniversitair Ziekenhuis Brussel
Jan 10, 2022
Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal
Not yet recruiting
- Esophagus Cancer
- +4 more
- Intravenous injection of P-IL-2
- P-IL-2 plus Anti-PD-1 Monoclonal Antibody
- (no location specified)
Apr 24, 2023
Malaria Trial in Silver Spring (p52-/p36- GAP Vaccine, p52-p36- GAP Vaccine)
Terminated
- Malaria
- p52-/p36- GAP Vaccine
- p52-p36- GAP Vaccine
-
Silver Spring, MarylandWalter Reed Army Institute of Research
Oct 4, 2019
Myopia Trial in China, India (Single vision spectacle lens, Single vision spectacle lens + S.T.O.P.® Kit 1, Single vision
Not yet recruiting
- Myopia
- Single vision spectacle lens
- +4 more
-
Tianjin, Heping District, China
- +4 more
Nov 15, 2023